191 related articles for article (PubMed ID: 9622843)
1. [Unconventional transmissible agents: risk of transmission by blood].
Dormont D
Transfus Clin Biol; 1998 Apr; 5 Suppl 1():33S-35S. PubMed ID: 9622843
[No Abstract] [Full Text] [Related]
2. The safety of human blood: experimental TSE/prion infectivity studies.
Cervenakova L
Transfus Clin Biol; 2001 Jun; 8(3):260. PubMed ID: 11499973
[No Abstract] [Full Text] [Related]
3. Prion disease and blood transfusion.
Flanagan P; Barbara JA
Transfus Med; 1996 Sep; 6(3):213-5. PubMed ID: 8885149
[No Abstract] [Full Text] [Related]
4. Transmissible spongiform encephalopathies.
Sejvar JJ; Schonberger LB; Belay ED
J Am Vet Med Assoc; 2008 Dec; 233(11):1705-12. PubMed ID: 19046027
[No Abstract] [Full Text] [Related]
5. Prions: properties, occurrence, modes of transmission and relevance for blood transfusion and blood derivatives.
Yap PL; Leaver HA; Gillon J
Vox Sang; 1998; 74 Suppl 2():131-4. PubMed ID: 9704435
[No Abstract] [Full Text] [Related]
6. Vaccines against transmissible spongiform encephalopathies: an urgent need?
Bade S; Frey A
Hum Vaccin; 2008; 4(1):79-81. PubMed ID: 18441531
[No Abstract] [Full Text] [Related]
7. The risk of transmission of nvCJD by blood transfusion and the potential benefits of leucodepletion.
Turner M
Transfus Sci; 1998 Dec; 19(4):331-2. PubMed ID: 10351147
[No Abstract] [Full Text] [Related]
8. How to limit the spread of Creutzfeldt-Jakob disease.
Dormont D
Infect Control Hosp Epidemiol; 1996 Aug; 17(8):521-8. PubMed ID: 8875297
[TBL] [Abstract][Full Text] [Related]
9. Spongiform encephalopathies: a tale of cannibals, cattle, and prions.
Mariani SM
MedGenMed; 2003 Sep; 5(3):42. PubMed ID: 14600678
[No Abstract] [Full Text] [Related]
10. [The prion hypothesis and the human prion diseases].
Aguzzi A
Berl Munch Tierarztl Wochenschr; 2002; 115(3-4):91-8. PubMed ID: 11938572
[TBL] [Abstract][Full Text] [Related]
11. The French surveillance network of Creutzfeldt-Jakob disease. Epidemiological data in France and worldwide.
Brandel JP; Peckeu L; Haïk S
Transfus Clin Biol; 2013 Sep; 20(4):395-7. PubMed ID: 23587616
[TBL] [Abstract][Full Text] [Related]
12. Variant Creutzfeldt Jakob Disease.
Painter MJ
J Infect; 2000 Sep; 41(2):117-24. PubMed ID: 11023754
[No Abstract] [Full Text] [Related]
13. Removal of TSE agents from blood products.
Foster PR
Vox Sang; 2004 Jul; 87 Suppl 2():7-10. PubMed ID: 15209867
[No Abstract] [Full Text] [Related]
14. Transmissible spongiform encephalopathy agents and animal sera.
Dormont D
Dev Biol Stand; 1999; 99():25-34. PubMed ID: 10404872
[No Abstract] [Full Text] [Related]
15. [Prevention of prion diseases in a hospital setting. Protocol used at the Ospedale Bellaria di Bologna].
Suzzi R; Ricci A; Corazza G; Bolini G; Benati L; Michelucci R; Riccioni L; Fabrizi A; Roncaroli F
Pathologica; 1997 Aug; 89(4):449-53. PubMed ID: 9471616
[No Abstract] [Full Text] [Related]
16. Inactivation of the causal agents of Creutzfeldt-Jakob disease and other human prion diseases.
Taylor D
Brain Pathol; 1996 Apr; 6(2):197-8. PubMed ID: 8737933
[No Abstract] [Full Text] [Related]
17. Advances in screening test development for transmissible spongiform encephalopathies.
Cervenakova L; Brown P
Expert Rev Anti Infect Ther; 2004 Dec; 2(6):873-80. PubMed ID: 15566331
[TBL] [Abstract][Full Text] [Related]
18. [Much news on the prion front].
Norrby E
Lakartidningen; 2010 May 5-11; 107(18):1218-24. PubMed ID: 20521593
[No Abstract] [Full Text] [Related]
19. [Clinical management of prion disease].
Itoyama Y
No To Shinkei; 1997 Aug; 49(8):707-11. PubMed ID: 9282364
[No Abstract] [Full Text] [Related]
20. Prion disease: the shape of things to come.
Khamsi R
Nature; 2006 Jan; 439(7073):134-5. PubMed ID: 16407924
[No Abstract] [Full Text] [Related]
[Next] [New Search]
